SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T - Tender offer statement by Third Party:
SEC Accession No. 0001140361-22-022095
Filing Date
2022-06-07
Accepted
2022-06-07 09:04:33
Documents
8
Group Members
INNOVIVA MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T ny20004305x6_sctot.htm SC TO-T 104084
2 EXHIBIT (A)(1)(A) ny20004305x6_exa1a.htm EX-99.(A)(1)(A) 720283
3 EXHIBIT (A)(1)(B) ny20004305x6_exa1b.htm EX-99.(A)(1)(B) 133537
4 EXHIBIT (A)(1)(C) ny20004305x6_exa1c.htm EX-99.(A)(1)(C) 15462
5 EXHIBIT (A)(1)(D) ny20004305x6_exa1d.htm EX-99.(A)(1)(D) 33949
6 EXHIBIT (A)(1)(E) ny20004305x6_exa1e.htm EX-99.(A)(1)(E) 30559
7 FILING FEES TABLE ny20004305x6_ex107.htm EX-FILING FEES 21204
8 logo_computershare.jpg GRAPHIC 36052
  Complete submission text file 0001140361-22-022095.txt   1110473
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filed by) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Subject) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T | Act: 34 | File No.: 005-90651 | Film No.: 22999975
SIC: 2834 Pharmaceutical Preparations